StartupLanes

Top 10 “HealthCare” Startups in Singapore!!

Singapore has a strong reputation for health services and healthcare systems; in 2000, the country was ranked sixth in the world by the World Health Organization. Public hospitals have autonomy over management decisions, and compete with one another for patients. General hospitals have a variety of functions and services; they mainly represent multi-disciplinary acute inpatient and specialist outpatient services, have 24-hour emergency centers, and often specialize in a specific field of medicine (cancer research, neuroscience, dental care, cardiac care, etc.). Singapore has an array of hospitals and health services available, as well as community hospitals that exist as an intermediate form of healthcare for people who do not require the services of a general hospital but cannot cope at home.

The funding behind Singapore’s public health sector can be broken down into the Ministry of Health of Singapore, Medisave, MediShield Life, and MediFund. Singapore’s healthcare system uses a mixed financing system that includes nationalised life insurance schemes and deductions from the compulsory savings plan, or Central Provident Fund (CPF), for working Singaporeans and permanent residents.

Top 10 HealthCare Startups in Singapore:

  1. Aslan Pharmaceuticals

ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is currently evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. ASLAN has a team in Menlo Park, California, and in Singapore.

Their leading investors are Armentum Partners, Surveyor Capital and Vivo Capital.

2. Doctor Anywhere

At Doctor Anywhere, they are guided by the core belief that healthcare should be simple, accessible and efficient for everyone. Since their launch in 2017, they’ve been disrupting the healthcare industry by developing innovative solutions to bridge gaps in the healthcare ecosystem. Their services integrate both digital and offline platforms to empower users to take charge of their health. Headquartered in Singapore, we have regional offices in Malaysia, Thailand, Philippines, Vietnam, and India, serving more than 2.5 million (and growing) users across Asia.

Their leading investors are Square Peg Capital and Kamet Capital Partners.

3. CXA Group

CXA Group is Asia’s one-stop, predictive and data intelligence platform for better health, wealth and wellness choices. Through the CXA platform, employers can empower employees with access to personalised health and lifestyle offerings, with clear and quantifiable ROI for the business. They enable employers to leverage their existing healthcare and insurance spend to pay for flexible benefits, corporate wellness and disease management initiatives in order to improve health, combat chronic disease and reduce costs while allowing for employee personalization via an e-wallet and AI.

Their leading investors are MDI Ventures, B Capital Group, Singtel Innov8 and HSBC.

4. Zenyum

Zenyum is on a mission to help Asia smile more. They’re a consumer-focused healthcare brand that removes medical jargon, cancelled appointments, price variations and puts convenience at the centre of your smile journey. Affordable dental treatment that actually works. Founded in 2018 in Singapore, Zenyum provides Smile Cosmetics, produced under the highest quality standards. Led by a team of experienced tech entrepreneurs and doctors, they bring the highest level of care to our customers by partnering with experienced local dentists across Asia. Zenyum operates in Singapore, Malaysia, Hong Kong, Indonesia, Taiwan, Thailand, and Vietnam.

Their leading investors are L Catterton Asia, RTP Global, TNB Aura and Partech.

5. Engine Biosciences

Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Their proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. They are actively applying the platform internally and with partners across a range of disease indications.

Their leading investors are Polaris Partners, Baidu Ventures and EDB.

6. Homage

Homage is a leading technology-driven care and health services platform that combines curated and trained care professionals with smart technology to manage and provide on-demand holistic non-medical and medical services to seniors and adults, allowing them to age and recover at home with grace, control and dignity. Homage’s core care services include Disability and Care Assessments, Activities of Daily Living (ADL) assistance, Nursing Procedures and Rehabilitation services, including Physiotherapy, Speech Therapy and Occupational Therapy. Additionally, Homage Health provides health screening, mobile medicine, telemedicine, ambulance and medication delivery services.

Their leading investors are Sheares Healthcare, SeedPlus and East Ventures.

7. Holmusk

Holmusk is a data science and health technology company dedicated to establishing objective evidence as a core utility to the treatment of mental health and chronic diseases. Founded in 2015, Holmusk is headquartered in Singapore and New York City with offices in Basel, London, Malaysia, Shanghai, and Durham (North Carolina). Holmusk was recognized as a Technology Pioneer in 2019 by the World Economic Forum and is part of the Innovations in Healthcare’s 2020 Innovator Cohort. Holmusk’s vision is to build the world’s largest Real-World Evidence (RWE) platform and enable a leapfrog-change in research and the provision of care through machine learning, deep learning and digital tools.

Their leading investors are Optum Ventures, Health Catalyst Capital and Heritas Capital.

8. AUM Biosciences

AUM is a clinical-stage biopharmaceutical company aiming to democratize R&D with a focus on discovering, acquiring, and developing novel therapeutics in oncology. The company holds exclusive worldwide rights in all disease indications for 2 first-in-class technologies with strong composition of matter patents in all major territories. MNK Inhibition and Multi-Kinase Inhibition (PIM/PI3K/mTOR). AUM utilizes a proprietary partnered AI-augmented platform to systematically discover and develop targeted cancer therapies focused on genetic targets. AUM’s most advanced program is Phase II ready in colorectal cancer, and 2 additional pre-clinical programs have clear pathways to orphan drug designation.

Their leading investors are Everlife and SPRIM.

9. DocDoc

DocDoc is the world’s first patient intelligence company. Their vision is to empower patients to make data-driven healthcare decisions which are safe, transparent, and fair. They use technology in conjunction with medically trained professionals to optimise healthcare outcomes and cost, and enhance the patient’s end-to-end healthcare journey. DocDoc combines AI-powered doctor discovery, telemedicine, and digital Third Party Administrator services onto a single platform. With this platform, DocDoc enables insurance companies to offer a differentiated product in a crowded market, employers to attract and retain world-class employees, and governments to improve accessibility and affordability of healthcare services for their citizens.

Their leading investors are Adamas Finance Asia, CyberPort Marco Fund and Yee How Choong.

10. Attune Technologies

Attune Technologies is a next-generation healthcare IT company that has pioneered Cloud based products designed to help the entire healthcare ecosystem. Attune’s solutions seamlessly integrate Labs, Hospitals, Pharmacies, Blood Banks, Radiology, Medical Devices (IoT), Insurance Companies, and Accounting resulting in increased revenues and operational efficiency. Attune’s solutions can be deployed across the spectrum of organizations – starting from single physician clinics to a network of healthcare providers making it the largest Cloud based healthcare IT service provider in the region. Funded by Norwest Venture Partners and Qualcomm Ventures, Attune is headquartered in Singapore and supports over 10 million patient health records serving 200+ clients spread across 15 countries in the Indian Subcontinent, South East Asia, Middle East and Africa.

Their leading investors are Norwest Venture Partners and Qualcomm Ventures.

For any corrections or nominations, Please mail isha@startuplanes.com

Exit mobile version